1
Investors
About
Affimed is a clinical-stage biotechnology company developing antibody-based and cell therapies that engage innate immune cells to treat hematological malignancies and solid tumors.
Explore Affimed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.